Beta-o2 Technologies Ltd.
Beta-O2 is developing the ßAir Bio-artificial Pancreas, intended to cure Type 1 diabetes (TID).
15 employees · est. 2004 · Israel
Orgenesis Inc.
Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)
65 employees · est. 2012 · Germantown, United States
Beta-o2 Technologies Ltd. is the older company (2004 vs 2012); Orgenesis Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Beta-o2 Technologies Ltd. | Orgenesis Inc. |
|---|---|---|
| Founded | ||
| Founded | 2004 older | 2012 |
| Headquarters | ||
| Headquarters | Israel | Germantown, United States |
| Employees | ||
| Employees | 15 | 65 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Grant |
| Total Funding | ||
| Total Funding | $3.00M | $69.12M |
| Funding Rounds | ||
| Funding Rounds | 3 | 9 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biomedical, Diabetes Treatment, Type 1 Diabetes, Islet Transplantation, Immunosuppressive Therapy, Bioreactor, Insulin Production, Medical Innovation | Biotech, Cell Therapy, Gene Therapy, POCare Network, Decentralized Production, Diabetes Treatment, Autologous Insulin Producing (AIP) Cell Transplantation, Beta Cell Replacement, Pancreas Islet Transplantation, Clinical Trials, FDA Guidelines, Molecular And Cellular Approach, Global Biotech Company, Organ Regeneration, Insulin-dependent Diabetes Mellitus |
| Website | ||
| Website | beta-o2.com | orgenesis.com |
About Beta-o2 Technologies Ltd.
Beta-o2 Technologies Ltd. is a biotechnology startup based in Israel, founded in 2004. The company is focused on developing the ßAir Bio-artificial Pancreas with the purpose of curing Type 1 diabetes (TID). This groundbreaking technology aims to provide a viable and safe environment for islets of La...
About Orgenesis Inc.
Orgenesis Inc. is a leading global biotech company committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2008. The company's slogan, "Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)", reflects its core mission. In 2020, Orgenesis initiated...
We will tell you when either one moves
BounceWatch watches Beta-o2 Technologies Ltd. and Orgenesis Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Beta-o2 Technologies L... and Orgenesis Inc. — by email.
Frequently Asked Questions
Compare Beta-o2 Technologies Ltd. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Beta-o2 Technologies Ltd. on 12 Sep 2024, and Orgenesis Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.